Shares in the penny stock of OncoSec Medical Inc. (OTC: ONCS), which is developing its advanced-stage ElectroOncology therapies to treat solid tumors, look to continue their rally this week. ONCS announced prior to the market open positive interim analysis of their Phase IV study from 81 subjects in a primary and locally recurrent squamous cell carcinoma of the head ...
Continue Reading →APR